TSS
ACET icon

Two Sigma Securities’s Adicet Bio ACET Stock Holding History

Two Sigma Securities’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,580
Closed -$20.5K – 1430
2025
Q3 		$20.5K Buy
+1,580
New +$18.6K ﹤0.01% 1135
2024
Q4 		– Sell
-1,456
Closed -$33.5K – 1568
2024
Q3 		$33.5K Buy
+1,456
New +$32.6K ﹤0.01% 2421
2023
Q3 		– Sell
-1,138
Closed -$44.2K – 2862
2023
Q2 		$44.2K Buy
+1,138
New +$100K ﹤0.01% 2411

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Two Sigma Securities's ACET Position: Q4 2025 in Review

Two Sigma Securities sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 1,580 shares — an estimated $20.5K sold.

Two Sigma Securities first reported a position in ACET in Q2 2023 and held it in 3 quarters. The position peaked at $44.2K in Q2 2023. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Two Sigma Securities reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,580 Adicet Bio shares in Q4 2025, an estimated $20.5K.
  • Two Sigma Securities first reported a position in Adicet Bio in Q2 2023 and held it in 3 quarters.
  • Two Sigma Securities's Adicet Bio position peaked at $44.2K in Q2 2023.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.